Chemotherapy of stage IIi and IV ovarian carcinoma
Neijt, J.P.; Barents, J.W.; Vendrik, C.P.; van Lindert, A.C.; Struyvenberg, A.; Pinedo, H.M.
Nederlands Tijdschrift Voor Geneeskunde 124(38): 1601-1605
1980
ISSN/ISBN: 0028-2162 PMID: 7412949 Document Number: 157871
Document emailed within 1 workday
Related Documents
Nickie-Psikuta, M.; Sablińska, B.; Kamińska, G. 1981: Effectiveness of radiotherapy and chemotherapy in stage IIi ovarian cancer Ginekologia Polska 52(6): 533-538Nishikawa, A.; Hashimoto, H.; Takeda, M.; Kontani, K.; Miyatake, T.; Mimura, M.; Nagamatsu, M.; Yokoi, T. 2016: Retrospective analysis of the survival benefit of chemotherapy for recurrent or advanced epithelial ovarian carcinoma in patients previously treated with paclitaxel plus platinum-based chemotherapy European Journal of Gynaecological Oncology 37(4): 451-454
Segev, Y.; Ismiil, N.; McVey, R.; Covens, A. 2015: Surgical Stage i high-grade ovarian cancer: is adjuvant chemotherapy warranted? European Journal of Gynaecological Oncology 36(6): 633-636
Vergote, I. 2001: Prognostic factors in stage i ovarian carcinoma Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 63(3): 257-271; Discussion: 272-276
Tanaka, N.; Matsui, H.; Nagai, Y.; Suzuka, K.; Seki, K.; Sekiya, S. 2002: Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer European Journal of Gynaecological Oncology 23(4): 281-286
Runhaar, E.A.; van Oosterom, A.T.; de Bruijn, E.A.; ten Bokkel Huinink, W.W. 1987: Intraperitoneal chemotherapy in ovarian carcinoma Netherlands Journal of Medicine 30(1-2): 94-103
Thigpen, J.T.; Vance, R.B.; Lambuth, B.W. 1988: Ovarian carcinoma: the role of chemotherapy Seminars in Oncology 15(3 Suppl 3: 16-23
Bruntsch, U.; Gallmeier, W.M. 1983: Chemotherapy of epithelial ovarian carcinoma Münchener Medizinische Wochenschrift 125(44): 993-995
Priolo, D.; Antonelli, G.; Calì, S.; Colina, P.; Giuffrida, D.; Malaponte, E.; Mattina, M.; Parisi, A.; Sambataro, D.; Vitale, F.; Ferraù, F. 2001: Second-line chemotherapy and new drugs for ovarian carcinoma La Clinica Terapeutica 152(1): 39-50
Zakrzewska, I.; Poznański, J. 2001: Changes of serum il-6 and CRP after chemotherapy in patients with ovarian carcinoma Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 11(63): 210-213
Puls, L.E.; Carrasco, R.; Morrow, M.S.; Blackhurst, D. 1997: Stage I ovarian carcinoma: specialty-related differences in survival and management Southern Medical Journal 90(11): 1097-1100
Biesma, B.; Willemse, P.H.; Vellenga, E.; Limburg, P.C.; Aalders, J.G.; de Vries, E.G. 1991: The hematopoietic growth factor GM-CSF in chemotherapy for ovarian carcinoma Nederlands Tijdschrift Voor Geneeskunde 135(10): 420-424
Lazarov, N.; Lazarov, L.; Lazarov, S. 2013: Tumor size and prognosis for patients with epithelial ovarian carcinoma at early stage Akusherstvo i Ginekologiia 52(4): 10-12
Kajino, T.; Higuchi, M.; Hata, K.; Shibata, N. 1996: Combination therapy with irinotecan and CBDCA for patients in terminal stage of ovarian carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(1): 115-117
Geisler, J.P.; Crook, D.E.; Geisler, H.E.; Cudahay, T.J.; Fraiz, J.; Bunce, C.P.; Moore, D.K.; Kay, K. 2000: The great imitator: miliary peritoneal tuberculosis mimicking stage III ovarian carcinoma European Journal of Gynaecological Oncology 21(2): 115-116
Akilli, H.; Rahatli, S.; Tohma, Y.A.; Karakas, L.A.; Altundag, O.; Ayhan, A. 2018: Effect of increased number of neoadjuvant chemotherapy cycles on tumor resectability and pathologic response in advanced stage epithelial ovarian cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 23(7): 111-115
Greenspan, E.M.; Bruckner, H.W. 1975: Comparison of regression induction with triethylenethiophosphoramide or methotrexate in bulky stage IIIb ovarian carcinoma National Cancer Institute Monograph 42: 173-175
Vardi, J.R.; Tadros, G.H.; Zamurovic, D.; Rafla, S.D. 1992: Tumor debulking followed by immediate combination chemotherapy in advanced ovarian carcinoma. Phase II Acta Obstetricia et Gynecologica Scandinavica 71(5): 361-367
Ottevanger, P.B. 2009: Intraperitoneal chemotherapy in ovarian carcinoma. Life prolonging in selected patients Nederlands Tijdschrift Voor Geneeskunde 153(11): 503-507
Scotto, V.; Sbiroli, C. 1991: Weekly cis-platinum as third line chemotherapy in advanced ovarian carcinoma. Phase Ii study European Journal of Gynaecological Oncology 12(1): 51-53